[ad_1]
These are preliminary results obtained with the volunteers 42 days after the injection of the first doseThe center, the Russian Ministry of Health and the Russian sovereign fund involved in the development of the vaccine said in a statement.
The second interim analysis of data from the third phase of the Russian coronavirus vaccine Sputnik V vaccine on nearly 19,000 volunteers showed efficacy of 91.4% on day 28 after the first injection and more than 95%. for day 42 after the first inoculation, the Russian portal Actualidad RT reported.
For its part, the Efe agency reports that a total of 14,095 volunteers received the vaccine and 4,699 the placebo, according to the official note.
Currently, 40,000 volunteers are participating in phase three, of which more than 22,000 have been injected with the first dose and 19,000 have received both the first and second.
During the analyzes, Russian experts found no “unexpected” adverse reactions to the Sputnik V vaccine among the volunteers who want to be immunized against COVID-19.
Sputnik V costs half as much as Moderna and Pfizer’s vaccines
The FIDR has shown that the price, less than $ 10 for one serving, is twice less than the vaccines that use mRMA, namely American Moderna and Pfizer. The vaccine would be free in Russia.
In addition, Russia has already started production of the dehydrated vaccine, based on freeze-drying technology, which will greatly facilitate your transportation to international markets, including hard-to-reach regions and others with tropical climates, an advantage over its competitors, which require low storage temperatures, down to minus 70 degrees Celsius in Pfizer’s case and minus 20 in Pfizer’s case. Modern
The first batch of Sputnik V for the foreign market will reach customers in January 2021 on the basis of agreements already signed with foreign partners.
The following video explains the differences between the Sputnik V, Pfizer BioNTech, Moderna and Oxford vaccines:
.
[ad_2]
Source link
